OGN

Organon & Co.

$8.70

+1.87%
Apr 14, 2026
Bobby Quantitative Model

People also watch

Eli Lilly and Company

Eli Lilly and Company

LLY

Analysis
Johnson & Johnson

Johnson & Johnson

JNJ

Analysis
AbbVie

AbbVie

ABBV

Analysis
Merck & Co.

Merck & Co.

MRK

Analysis
Amgen

Amgen

AMGN

Analysis

OGN price trend

Historical Price
Current Price $8.7
Average Target $8.7
High Target $10.004999999999999
Low Target $7.395

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Organon & Co.'s 12-month outlook, with a consensus price target around $11.31 and implied upside of +30.0% versus the current price.

Average Target

$11.31

3 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

3

covering this stock

Price Range

$7 - $11

Analyst target range

Buy
0 (0%)
Hold
1 (33%)
Sell
2 (67%)

Drowning in data?

Find the real signal!

OGN Technical Analysis

Beta

0.64

0.64x market volatility

Max Drawdown

-63.9%

Largest decline past year

52-Week Range

$6-$13

Price range past year

Annual Return

-23.0%

Cumulative gain past year

PeriodOGN ReturnS&P 500
1m+37.0%+4.9%
3m+1.0%+0.6%
6m-7.2%+5.1%
1y-23.0%+28.8%
ytd+20.2%+1.8%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Valuation Analysis: Is OGN Overvalued?

PE

9.9x

Latest Quarter

vs. Historical

N/A

5-Year PE Range 17x~59x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

7.9x

Enterprise Value Multiple

Investment Risk Disclosure